The interplay between cell signalling and the mevalonate pathway in cancer

PJ Mullen, R Yu, J Longo, MC Archer… - Nature Reviews Cancer, 2016 - nature.com
The mevalonate (MVA) pathway is an essential metabolic pathway that uses acetyl-CoA to
produce sterols and isoprenoids that are integral to tumour growth and progression. In …

Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy

B Marengo, M Nitti, AL Furfaro, R Colla… - Oxidative medicine …, 2016 - Wiley Online Library
Reactive oxygen species (ROS) and their products are components of cell signaling
pathways and play important roles in cellular physiology and pathophysiology. Under …

[HTML][HTML] Recent advances in drug repositioning for the discovery of new anticancer drugs

JS Shim, JO Liu - International journal of biological sciences, 2014 - ncbi.nlm.nih.gov
Drug repositioning (also referred to as drug repurposing), the process of finding new uses of
existing drugs, has been gaining popularity in recent years. The availability of several …

HIV infection and survival among women with cervical cancer

S Dryden-Peterson, M Bvochora-Nsingo… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Cervical cancer is the leading cause of cancer death among the 20 million women
with HIV worldwide. We sought to determine whether HIV infection affected survival in …

Targeting DNA double-strand break repair pathways to improve radiotherapy response

M Toulany - Genes, 2019 - mdpi.com
More than half of cancer patients receive radiotherapy as a part of their cancer treatment.
DNA double-strand breaks (DSBs) are considered as the most lethal form of DNA damage …

Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation

M Toulany, HP Rodemann - Seminars in cancer biology, 2015 - Elsevier
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is a key cascade downstream
of several protein kinases, especially membrane-bound receptor tyrosine kinases, including …

Pharmacological targeting of endoplasmic reticulum stress signaling in cancer

AH Schönthal - Biochemical pharmacology, 2013 - Elsevier
The endoplasmic reticulum (ER) stress response constitutes a cellular process that can be
triggered by a great variety of conditions that cause imbalances in intracellular homeostasis …

Approach to patients with pancreatic cancer without detectable metastases

GM Heestand, JD Murphy, AM Lowy - Journal of clinical oncology, 2015 - ascopubs.org
The poors outcomes associated with pancreatic cancer clearly reflect the advanced stage of
disease at diagnosis for most patients. Through this lens, it is easy to lose sight of the fact …

Anti-HIV drugs for cancer therapeutics: back to the future?

WA Chow, C Jiang, M Guan - The lancet oncology, 2009 - thelancet.com
The use of anti-HIV drugs as cancer treatments is not new. Azidothymidine was studied as
an antineoplastic in the 1990s, but despite promising in vitro data, clinical trials showed little …

HIV‐1, HAART and cancer: a complex relationship

A Shmakova, D Germini… - International journal of …, 2020 - Wiley Online Library
HIV infected people are at higher risk of developing cancer, although it is globally
diminished in the era of highly active antiretroviral treatment (HAART). Recently …